Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
April 11 (Reuters) - ISR IMMUNE SYSTEM REGULATION
HOLDING AB ISR.ST :
* SAID ON FRIDAY CO HAS BEEN INFORMED THAT NASDAQ STOCKHOLM
HAS
DECIDED TO HAND OVER THE ONGOING INVESTIGATION CASE TO THE
DISCIPLINARY COMMITTEE WITH A REQUEST FOR DELISTING
* CASE, REQUEST FOR DELISTING DUE TO NASDAQ CONSIDERING THAT
ISR
HOLDING HAS VIOLATED PROVISIONS OF NASDAQ FIRST NORTH GROWTH
MARKET RULEBOOK
Source text for Eikon: urn:newsml:reuters.com:*:nWkrc34BkJ
Further company coverage: ISR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent